Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis.

Mowry EM, James JA, Krupp LB, Waubant E.

Mult Scler. 2011 Jun;17(6):666-71. doi: 10.1177/1352458510394398. Epub 2011 Jan 6. Erratum in: Mult Scler. 2011 Dec;17(12):1539.

2.

Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.

Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, James JA.

Mult Scler. 2013 Jun;19(7):891-5. doi: 10.1177/1352458512469693. Epub 2012 Dec 11.

3.

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.

Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernán MA, Olek MJ, Hankinson SE, Hunter DJ.

JAMA. 2001 Dec 26;286(24):3083-8.

PMID:
11754673
4.

Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.

Salzer J, Nyström M, Hallmans G, Stenlund H, Wadell G, Sundström P.

Mult Scler. 2013 Oct;19(12):1587-91. doi: 10.1177/1352458513483888. Epub 2013 Apr 2.

PMID:
23549431
5.

Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis.

Décard BF, von Ahsen N, Grunwald T, Streit F, Stroet A, Niggemeier P, Schottstedt V, Riggert J, Gold R, Chan A.

J Neurol Neurosurg Psychiatry. 2012 Dec;83(12):1170-3. doi: 10.1136/jnnp-2012-303068. Epub 2012 Aug 11.

PMID:
22888143
6.

Epstein-Barr virus in pediatric multiple sclerosis.

Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B.

JAMA. 2004 Apr 21;291(15):1875-9.

PMID:
15100207
7.

Risk factors for multiple sclerosis and associations with anti-EBV antibody titers.

Mouhieddine TH, Darwish H, Fawaz L, Yamout B, Tamim H, Khoury SJ.

Clin Immunol. 2015 May;158(1):59-66. doi: 10.1016/j.clim.2015.03.011. Epub 2015 Mar 21.

PMID:
25805657
8.

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.

Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A.

JAMA. 2005 May 25;293(20):2496-500.

PMID:
15914750
9.

Common viruses associated with lower pediatric multiple sclerosis risk.

Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Chabas D, Strober J, McDonald J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, Oksenberg JR, James JA; US Pediatric MS Network.

Neurology. 2011 Jun 7;76(23):1989-95. doi: 10.1212/WNL.0b013e31821e552a.

10.

The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.

Najafipoor A, Roghanian R, Zarkesh-Esfahani SH, Bouzari M, Etemadifar M.

Cell Immunol. 2015 Mar;294(1):9-12. doi: 10.1016/j.cellimm.2015.01.009. Epub 2015 Jan 28.

PMID:
25666504
11.

Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.

Munger KL, Levin LI, O'Reilly EJ, Falk KI, Ascherio A.

Mult Scler. 2011 Oct;17(10):1185-93. doi: 10.1177/1352458511408991. Epub 2011 Jun 17.

12.

Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway.

Myhr KM, Riise T, Barrett-Connor E, Myrmel H, Vedeler C, Grønning M, Kalvenes MB, Nyland H.

J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):539-42.

13.

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA.

Brain. 2008 Jul;131(Pt 7):1712-21. doi: 10.1093/brain/awn108. Epub 2008 Jun 11.

PMID:
18550621
14.

Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort.

Munger KL, Åivo J, Hongell K, Soilu-Hänninen M, Surcel HM, Ascherio A.

JAMA Neurol. 2016 May 1;73(5):515-9. doi: 10.1001/jamaneurol.2015.4800.

15.

Multiple sclerosis and Epstein-Barr virus.

Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A.

JAMA. 2003 Mar 26;289(12):1533-6. Retraction in: Ascherio A, Rubertone M, Spiegelman D, Levin L, Munger K, Peck C, Lennette E. JAMA. 2005 May 25;293(20):2466.

PMID:
12672770
16.

Serological evidence of herpesvirus infection in gibbons.

Sakulwira K, Theamboonlers A, Charoonrut P, Ratanakorn P, Poovorawan Y.

BMC Microbiol. 2002 May 31;2:11.

17.
18.

Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents.

Rosenthal SL, Stanberry LR, Biro FM, Slaoui M, Francotte M, Koutsoukos M, Hayes M, Bernstein DI.

Clin Infect Dis. 1997 Feb;24(2):135-9.

PMID:
9114136
19.

Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis.

Pohl D, Rostasy K, Jacobi C, Lange P, Nau R, Krone B, Hanefeld F.

J Neurol. 2010 Feb;257(2):212-6. doi: 10.1007/s00415-009-5296-y. Epub 2009 Aug 28.

20.

Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes.

Martinelli V, Dalla Costa G, Colombo B, Dalla Libera D, Rubinacci A, Filippi M, Furlan R, Comi G.

Mult Scler. 2014 Feb;20(2):147-55. doi: 10.1177/1352458513494959. Epub 2013 Jul 8.

PMID:
23836877

Supplemental Content

Support Center